Literature DB >> 24648010

Different incubation times of cells after gene electrotransfer in fetal bovine serum affect cell viability, but not transfection efficiency.

Masa Bosnjak1, Beatriz Canals Lorente, Ziva Pogacar, Vesna Makovsek, Maja Cemazar.   

Abstract

Electroporation as a delivery method is increasingly important in gene therapy, not only in vivo but also in in vitro experimental systems. Different applications of gene electrotransfer require high viability of cells and high transfection efficiency of gene electrotransfer. It was already demonstrated that the addition of fetal bovine serum (FBS) immediately after gene electrotransfer leads to improved cell survival and transfection efficiency. Therefore, the aim of the study was to determine whether prolonged incubation of cells in FBS, for more than standard 5 min, can lead to increased transfection efficiency and improved cell survival. Different murine melanoma and murine and human endothelial cell lines were transfected with plasmid encoding green fluorescent protein and then incubated for different periods of time in FBS (5-30 min). Transfection efficiency was determined by flow cytometry and fluorescence microscopy and cell survival by cell viability assay. Prolonged incubation of cells in FBS after gene electrotransfer had varying effect on cell survival, which was decreased in melanoma cell lines B16F1 and B16F10, minimally affected in SVEC4-10 and HUVEC cells and increased in 2H11 cell at 30 min of incubation time in FBS. On the other hand, transfection efficiency of gene electrotransfer was not affected by long incubation of cell in FBS, regardless of the cell line used. The results of our study emphasize the importance of optimization of gene electrotransfer protocol for particular cells and specific purposes of gene electrotransfer, taking into account the importance of transfection efficiency and cell survival.

Entities:  

Mesh:

Year:  2014        PMID: 24648010     DOI: 10.1007/s00232-014-9649-9

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  41 in total

1.  In vivo gene delivery by electroporation.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-01-04       Impact factor: 15.470

2.  In vivo electrically mediated protein and gene transfer in murine melanoma.

Authors:  M P Rols; C Delteil; M Golzio; P Dumond; S Cros; J Teissie
Journal:  Nat Biotechnol       Date:  1998-02       Impact factor: 54.908

3.  Biological properties of melanoma and endothelial cells after plasmid AMEP gene electrotransfer depend on integrin quantity on cells.

Authors:  Masa Bosnjak; Lara Prosen; Tanja Dolinsek; Tanja Blagus; Bostjan Markelc; Maja Cemazar; Celine Bouquet; Gregor Sersa
Journal:  J Membr Biol       Date:  2013-05-07       Impact factor: 1.843

4.  Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients.

Authors:  G Sersa; B Stabuc; M Cemazar; D Miklavcic; Z Rudolf
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

5.  Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol.

Authors:  L M Mir; H Banoun; C Paoletti
Journal:  Exp Cell Res       Date:  1988-03       Impact factor: 3.905

Review 6.  Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis.

Authors:  B Mali; T Jarm; M Snoj; G Sersa; D Miklavcic
Journal:  Eur J Surg Oncol       Date:  2012-09-11       Impact factor: 4.424

Review 7.  Electrochemotherapy in treatment of tumours.

Authors:  G Sersa; D Miklavcic; M Cemazar; Z Rudolf; G Pucihar; M Snoj
Journal:  Eur J Surg Oncol       Date:  2007-07-05       Impact factor: 4.424

8.  Robust, efficient, and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses.

Authors:  Aaron Liew; Franck M André; Léa L Lesueur; Marie-Amélie De Ménorval; Timothy O'Brien; Lluis M Mir
Journal:  Hum Gene Ther Methods       Date:  2013-08-30       Impact factor: 2.396

9.  Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Authors:  Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; Vernon K Sondak; Pamela N Munster; Daniel M Sullivan; Kenneth E Ugen; Jane L Messina; Richard Heller
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

10.  Muscle gene electrotransfer is increased by the antioxidant tempol in mice.

Authors:  B Markelc; G Tevz; M Cemazar; S Kranjc; J Lavrencak; B Zegura; J Teissie; G Sersa
Journal:  Gene Ther       Date:  2011-06-30       Impact factor: 5.250

View more
  4 in total

1.  Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.

Authors:  Ursa Lampreht; Urska Kamensek; Monika Stimac; Gregor Sersa; Natasa Tozon; Masa Bosnjak; Andreja Brozic; Geraldo Gileno de Sá Oliveira; Takayuki Nakagawa; Kohei Saeki; Maja Cemazar
Journal:  J Membr Biol       Date:  2015-04-04       Impact factor: 1.843

2.  Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.

Authors:  Spela Kos; Natasa Tesic; Urska Kamensek; Tanja Blagus; Maja Cemazar; Simona Kranjc; Jaka Lavrencak; Gregor Sersa
Journal:  J Membr Biol       Date:  2015-04-04       Impact factor: 1.843

3.  Gene electrotransfer of plasmid AMEP, an integrin-targeted therapy, has antitumor and antiangiogenic action in murine B16 melanoma.

Authors:  M Bosnjak; T Dolinsek; M Cemazar; S Kranjc; T Blagus; B Markelc; M Stimac; J Zavrsnik; U Kamensek; L Heller; C Bouquet; B Turk; G Sersa
Journal:  Gene Ther       Date:  2015-04-09       Impact factor: 5.250

4.  Tumor cell death after electrotransfer of plasmid DNA is associated with cytosolic DNA sensor upregulation.

Authors:  Katarina Znidar; Masa Bosnjak; Nina Semenova; Olga Pakhomova; Loree Heller; Maja Cemazar
Journal:  Oncotarget       Date:  2018-04-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.